Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 10.54
+0.17 (1.64%)
May 27, 2026, 4:09 PM HKT
Abbisko Cayman Employees
Abbisko Cayman had 226 employees as of June 30, 2025. The number of employees decreased by 55 or -19.57% since the number was reported on December 31, 2024.
Employees
226
Change
-55
Growth
-19.57%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
7.55B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 226 | -55 | -19.57% |
| Dec 31, 2024 | 281 | 23 | 8.91% |
| Dec 31, 2023 | 258 | 8 | 3.20% |
| Dec 31, 2022 | 250 | 90 | 56.25% |
| Dec 31, 2021 | 160 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,110 |
| CK Life Sciences Int'l., (Holdings) | 1,920 |
| Everest Medicines | 812 |
| Lepu Biopharma | 710 |
| Ocumension Therapeutics | 552 |
| Alphamab Oncology | 498 |
| CARsgen Therapeutics Holdings | 355 |
| HBM Holdings | 210 |